These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 7634317

  • 21. Current concepts in coronary thrombolysis.
    Eisenberg PR.
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1161-70. PubMed ID: 1400079
    [Abstract] [Full Text] [Related]

  • 22. Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
    Granger CB, Becker R, Tracy RP, Califf RM, Topol EJ, Pieper KS, Ross AM, Roth S, Lambrew C, Bovill EG.
    J Am Coll Cardiol; 1998 Mar 01; 31(3):497-505. PubMed ID: 9502626
    [Abstract] [Full Text] [Related]

  • 23. Heparin management in acute myocardial infarction (AMI).
    Granger CB.
    Aust N Z J Med; 1998 Aug 01; 28(4):541-7. PubMed ID: 9777136
    [Abstract] [Full Text] [Related]

  • 24. [Unstable angina pectoris: coagulation disorder and its therapy].
    Meyer BJ.
    Praxis (Bern 1994); 1995 Feb 21; 84(8):232-8. PubMed ID: 7886362
    [Abstract] [Full Text] [Related]

  • 25. Newer antithrombin agents in acute coronary syndromes.
    Antman EM, Cohen M.
    Am Heart J; 1999 Dec 21; 138(6 Pt 2):S563-9. PubMed ID: 10577463
    [Abstract] [Full Text] [Related]

  • 26. [Coronary thrombosis--an old concept in a new light].
    Baur HR.
    Schweiz Rundsch Med Prax; 1992 Sep 22; 81(39):1147-51. PubMed ID: 1410998
    [Abstract] [Full Text] [Related]

  • 27. Hirulog in the treatment of unstable angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial.
    Fuchs J, Cannon CP.
    Circulation; 1995 Aug 15; 92(4):727-33. PubMed ID: 7641350
    [Abstract] [Full Text] [Related]

  • 28. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators.
    Circulation; 1994 Oct 15; 90(4):1631-7. PubMed ID: 7923645
    [Abstract] [Full Text] [Related]

  • 29. [Coronary insufficiency and heparin].
    Nicolau JC, Ramires JA.
    Arq Bras Cardiol; 1991 Aug 15; 57(2):141-50. PubMed ID: 1823773
    [No Abstract] [Full Text] [Related]

  • 30. [Thrombin-antithrombin III complexes as a measure of effective heparin treatment?].
    Meyer D, Tsakiris DA, Marbet GA.
    Schweiz Med Wochenschr; 1989 Sep 30; 119(39):1352-4. PubMed ID: 2678451
    [Abstract] [Full Text] [Related]

  • 31. Heparin and antiaggregating therapy in unstable angina.
    Neri Serneri GG, Modesti PA, Abbate R, Gensini GF.
    Haemostasis; 1990 Sep 30; 20 Suppl 1():113-21. PubMed ID: 2083863
    [Abstract] [Full Text] [Related]

  • 32. [Thrombosis in unstable angina. Is there a role for thrombolytic agents?].
    Raynaud P, Desveaux B, Pacouret G.
    Ann Cardiol Angeiol (Paris); 1989 Sep 15; 38(7):425-30. PubMed ID: 2686522
    [Abstract] [Full Text] [Related]

  • 33. Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes; the GUSTO-IIb haemostasis substudy.
    Kottke-Marchant K, Bahit MC, Granger CB, Zoldhelyi P, Ardissino D, Brooks L, Griffin JH, Potthoff RF, Van de Werf F, Califf RM, Topol EJ.
    Eur Heart J; 2002 Aug 15; 23(15):1202-12. PubMed ID: 12127922
    [Abstract] [Full Text] [Related]

  • 34. Plaque disruption and the acute coronary syndromes of unstable angina and myocardial infarction: if the substrate is similar, why is the clinical presentation different?
    Ambrose JA.
    J Am Coll Cardiol; 1992 Jun 15; 19(7):1653-8. PubMed ID: 1593062
    [Abstract] [Full Text] [Related]

  • 35. Coronary atherosclerosis and thrombosis underlying acute myocardial infarction.
    Saffitz JE, Schwartz CJ.
    Cardiol Clin; 1987 Feb 15; 5(1):21-30. PubMed ID: 3548973
    [Abstract] [Full Text] [Related]

  • 36. Thrombin and antithrombotics.
    Fenton JW, Ofosu FA, Brezniak DV, Hassouna HI.
    Semin Thromb Hemost; 1998 Feb 15; 24(2):87-91. PubMed ID: 9579630
    [Abstract] [Full Text] [Related]

  • 37. Persistent thrombin generation during heparin therapy in patients with acute coronary syndromes.
    Merlini PA, Ardissino D, Bauer KA, Oltrona L, Pezzano A, Bottasso B, Rosenberg RD, Mannucci PM.
    Arterioscler Thromb Vasc Biol; 1997 Jul 15; 17(7):1325-30. PubMed ID: 9261263
    [Abstract] [Full Text] [Related]

  • 38. Potential advantages of direct-acting thrombin inhibitors.
    Philippides GJ, Loscalzo J.
    Coron Artery Dis; 1996 Jul 15; 7(7):497-507. PubMed ID: 8913677
    [No Abstract] [Full Text] [Related]

  • 39. [The endothelium and antithrombotic substances].
    Eber B.
    Acta Med Austriaca; 1989 Jul 15; 16(5):102-4. PubMed ID: 2698051
    [Abstract] [Full Text] [Related]

  • 40. Antithrombotic therapy after myocardial reperfusion in acute myocardial infarction.
    Fuster V, Stein B, Badimon L, Chesebro JH.
    J Am Coll Cardiol; 1988 Dec 15; 12(6 Suppl A):78A-84A. PubMed ID: 3057038
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.